Basilea reports preclinical data on anti-cancer activity of novel oncology drug candidate BAL0891 at ESMO TAT congress
Press Release Basel, Switzerland, March 08, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical…
Month: March 2022
Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs
Voyager receives $54 million upfront with potential option exercise fees and milestone payments of up…
HIVE Blockchain Provides Update on February 2022 Production and At-The-Market Offering and Conclusion of Canadian At-The-Market Offering
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
Provenir Appoints Francisco Franch to Lead Expansion in Spain
Demand for company’s AI-powered risk decisioning software continues to drive global expansion PARSIPPANY, N.J.–(BUSINESS WIRE)–#AI—Provenir,…
Parallelle Finance Introduces the Parallelle Finance Gender Lens Scorecard
SEATTLE–(BUSINESS WIRE)–Parallelle Finance, a research, analysis, and advocacy firm focusing on gender lens equity and…
Phison Strengthens its Position in Automotive Storage Market: Secures Automotive Functional Safety Certification ISO 26262
Functional Safety Certification Enables the Company to Develop System-Critical Automobile Storage Solutions for Driverless Cars…
Zylpha Announces 2022 ‘Legal Innovation Award’ Winners
Leading UK Legal systems developer Zylpha (www.zylpha.com) has announced the winners of its annual ‘Legal…
Appear makes US debut at NAB 2022
Alongside launching North America operations, Appear expands its NEO Series offering with the release of…
Keynote 2022: myWorld presents its newest products and shopping innovations
The first myWorld Keynote of the year took place on the 5th of March in…
Roche to present new Evrysdi data at MDA 2022 and highlight expanding neuromuscular disease portfolio
Evrysdi® (risdiplam) data further confirm long-term efficacy and safety data in a broad range of…
Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate
VLA1553-301 six-month follow-up completed – all endpoints met Seroprotection (protective CHIKV neutralizing antibody levels) in…
LBank Exchange Will List Kiba Inu (KIBA) on March 9, 2022
Internet City, Dubai–(Newsfile Corp. – March 8, 2022) – LBank Exchange, a global digital asset…
LBank Exchange Will List Lustcoins (LUST) on March 10, 2022
Internet City, Dubai–(Newsfile Corp. – March 8, 2022) – LBank Exchange, a global digital asset…
o9 Solutions Drives Digital Supply Chain Transformation at Berger Paints
BANGALORE, India–(BUSINESS WIRE)–o9 Solutions, a leading enterprise AI-powered platform provider for integrated business planning and…
Trellix and Gotara Announce Partnership to Close Cybersecurity Talent Gap
Company Invests in Women to Become the Premier Cybersecurity Workplace SAN JOSE, Calif.–(BUSINESS WIRE)–Trellix, the…
Cyxtera to Speak at Upcoming Investor Conferences
MIAMI–(BUSINESS WIRE)–$CYXT #colocation—Cyxtera (NASDAQ: CYXT), a global leader in data center colocation and interconnection services,…
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment
MELBOURNE, Australia, March 08, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, “Telix”, the…
Acerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva™
Conference Call to be Held on March 9, 2022 at 8:30am ET to Discuss Transaction…
Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2021 Financial Results
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…